Company Filing History:
2 out of 3 
1 out of 832,812 Years Active: 2014-2021
Title: Giuseppe Pietro Pio Basta: Innovator in Cell and Molecular Therapy
Introduction
Giuseppe Pietro Pio Basta is a notable inventor based in Perugia, Italy. He has made significant contributions to the field of cell and molecular therapy, holding a total of 3 patents. His innovative work focuses on the development of advanced microencapsulation techniques that have the potential to revolutionize treatment methods for various diseases.
Latest Patents
One of his latest patents involves the creation of alginate microcapsules designed for cell and molecular therapy. These microcapsules are engineered to secrete bioactive immune molecules. The patent describes a membrane that includes a barrier composed of layers of alginate with varying material molar concentrations. This unique structure ensures a uniform consistency throughout the thickness of the layers, which is free of laminae and interfaces, resulting in a single layer morphology that allows for the permeability of selected molecules.
Another significant patent focuses on the clinical-grade sodium alginate used for the microencapsulation of myofibroblasts isolated from Wharton's jelly. This method aims to prevent and treat autoimmune and inflammatory diseases. The process involves isolating myofibroblasts from the human umbilical cord and encapsulating them in ultra-purified sodium alginate, forming a three-dimensional spherical structure.
Career Highlights
Throughout his career, Giuseppe has worked with various organizations, including Gh Care Inc. His innovative approaches and dedication to research have positioned him as a key figure in the field of biomedical engineering.
Collaborations
Giuseppe has collaborated with notable professionals in his field, including Riccardo Calafiore and Pia Montanucci. These partnerships have further enhanced his research and development efforts.
Conclusion
Giuseppe Pietro Pio Basta is a pioneering inventor whose work in cell and molecular therapy is paving the way for new treatment options. His patents reflect a commitment to advancing medical science and improving patient outcomes.